Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update2026-05-1123%External coverage
Adial Pharmaceuticals Submits Application to FDA Commissioner's National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program2026-04-2723%External coverage
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update2026-03-0623%External coverage
EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million2026-03-0347%External coverage
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One2026-02-233%External coverage
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update2025-11-1423%External coverage
Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder2025-09-1623%External coverage